Engitix

Engitix specializes in developing tissue-engineered products for regenerative medicine and drug-target research, utilizing its proprietary human organ decellularization technology. The company's main focus is on liver disease, leveraging its expertise in human extracellular matrix (ECM) scaffolds and 3D spheroids to create bioartificial liver devices. Additionally, Engitix is expanding its technology applications to other organs and conditions, including pancreatic and intestinal diseases. By creating tissue-specific and disease-specific ECMs, Engitix aims to enhance the drug discovery process in fibrosis and oncology, ultimately improving the quality of life for patients with advanced fibrosis and solid tumors.